Abstract:Stroke is a vascular disease in which brain cell death is initiated by a great reduction in blood flow. Only a few minutes of markedly lowered local blood flow (focal ischemia) may injure neurons and non-neuronal cells (e.g., endothelial cells and astrocytes) and lead to their death. Vasculogenesis is a process in which angioblasts differentiated into endothelial cells to form a primitive capillary network; whereas angiogenesis is the sprouting of capillaries from pre-existing blood vessels. Both mechanisms may contribute to neovascularization during embryogenesis and repair of damaged tissues in adults. The multi-potent embryonic stem (ES) cells can differentiate into neural cells and endothelial cells in vitro and in vivo. The multi-potentiality of ES cells provides a potential strategy for repairing the damaged brain after ischemic stroke. To examine the feasibility of ES cell transplantation in the ischemic brain and functional benefits of neovascularization, this study explored differentiations of transplanted ES cells in a rodent focal ischemia model. Transient focal cerebral ischemia was induced in adult male animals by 30-min occlusion of middle cerebral artery. Mouse ES cells were differentiated down neural lineages using the retinoic acid "4-/4+" protocol. To be able to identify ES cells after transplantation, ES cells were genetically marked with green fluorescent protein GFP or pre-labeled with BrdU and Hoechst. ES cell transplantation was performed 7 days after ischemia. Differentiation of ES cells was demonstrated by specific antibodies including MAP2, neurofilament, NeuN for neuron-like cells, GFAP for astrocytes, NG-2 for oligodendrocytes, Glut-1 and CD-31 for endothelial cells. Transplanted ES cells survived, differentiated and form functional structure in the ischemic core and penumbra regions. ES cell-derived endothelial cells formed new vesicular structures 7–14 days after transplantation. Local blood flow measured by Laser Doppler restored in the former ischemic region. Stroke animals received ES cell transplantation showed improved neurological and behavioral function 20–30 days after the transplantation. Our study demonstrates potential strategy of using ES cell transplantation to repair damaged brain tissues for reconstruction of neurovascular networks. The restoration of local blood supply and neuronal activities supports long-term functional benefits of ES cell transplantation after stroke (See Figure 1). Supported by NIH NS37373, NS45155, and AHA-Bugher Award 0170063N and 0170064N.

Abstract WP115: Transplanted Induced Neural Stem Cells Differentiate and Integrate into the Brain Parenchyma of Ischemic Stroke Pigs Leading to Improved Tissue Recovery

Abstract 130: Induced Neural Stem Cell Treated Stroke Pigs Show Improved White Matter Integrity and Brain Metabolism Post-ischemic Stroke

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model

Human iNPC therapy leads to improvement in functional neurologic outcomes in a pig ischemic stroke model

Human-Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Limits Tissue Damage and Promotes Tissue Regeneration and Functional Recovery in a Pediatric Piglet Traumatic-Brain-Injury Model

Pet Demonstrates Functional Recovery after Transplantation of Induced Pluripotent Stem Cells in A Rat Model of Cerebral Ischemic Injury

Ipsc Transplantation Increases Regeneration and Functional Recovery after Ischemic Stroke in Neonatal Rats

Tanshinone IIA-loaded nanoparticles and neural stem cell combination therapy improves gut homeostasis and recovery in a pig ischemic stroke model

Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model.

Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

Characterization of tissue and functional deficits in a clinically translational pig model of acute ischemic stroke

Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats

Vasculogenesis, angiogenesis and local blood flow recovery after embryonic stem cells transplantation in the ischemic brain

Human iPSC-derived cell grafts promote functional recovery by molecular interaction with stroke-injured brain

Transplantation of Ipsc Ameliorates Neural Remodeling and Reduces Ventricular Arrhythmias in a Post-Infarcted Swine Model.

Transplantation of iPS cell-derived neural progenitors overexpressing SDF-1α increases regeneration and functional recovery after ischemic stroke.

462 Stem Cell-Loaded Implantable Intrathecal Bioreactors for the Treatment of Spinal Cord Injury: A Porcine Model Pilot Study

Transplantation of Human Brain-Derived Ischemia-Induced Multipotent Stem Cells Ameliorates Neurological Dysfunction in Mice After Stroke

Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction.

Comparative study of the efficacy of intra-arterial and intravenous transplantation of human induced pluripotent stem cells-derived neural progenitor cells in experimental stroke